시장보고서
상품코드
1792281

기계식 인공호흡기 시장 보고서 : 제품 유형별, 인터페이스별, 연령층별, 환기 모드별, 최종 용도별, 지역별(2025-2033년)

Mechanical Ventilators Market Report by Product Type, Interface, Age Group, Mode of Ventilation, End-Use, and Region 2025-2033

발행일: | 리서치사: IMARC | 페이지 정보: 영문 146 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 기계식 인공호흡기 시장 규모는 2024년 57억 달러에 달했습니다. IMARC Group은 시장이 2033년까지 80억 달러에 이를 전망이며, 2025-2033년 3.9%의 성장률(CAGR)로 성장할 것으로 예측했습니다. 이 시장은 만성 폐색성 폐질환(COPD) 및 호흡기 질환의 유병률 상승, 고혈압, 당뇨병, 심혈관 질환을 앓고 있는 사람 증가, 비침습적이고 휴대 가능한 기계식 인공호흡기의 개발 등의 지속적인 기술 진보가 주요 요인이 되고 있습니다.

세계의 기계식 인공호흡기 시장 분석 :

  • 주요 시장 성장 촉진요인 : COPD, 천식, 폐렴과 같은 호흡기 질환의 유병률 증가 및 노인 인구 증가는 기계식 인공호흡기 시장의 성장을 가속하고 있습니다. 이 밖에 인공호흡기의 휴대성 향상, 모드, 사용자 인터페이스 개발 등 현재 진행 중인 기술 혁신이 시장 확대를 더욱 촉진하고 있습니다.
  • 주요 시장 동향 : 주로 신흥 경제 국가에서 헬스케어 지출이 증가하고 재택 치료라는 새로운 추세로 인한 재택 관리 환경에서 사용하기 쉽고 휴대 가능한 장비에 대한 수요 증가가 의료용 인공호흡기 시장 수요를 촉진하고 있습니다. 또한 자동화 기능과 최첨단 모니터링 기능을 갖춘 지능형 변종이 널리 사용됨에 따라 시장은 계속 성장하고 있습니다.
  • 경쟁 구도 : 기계식 인공 호흡기 시장의 주요 시장 기업은 Allied Healthcare Products, Air Liquide, Asahi Kasei, GE Healthcare Company, Hamilton Medical AG, Maquet GmbH & Co.KG(Gatenge), Medtronic Plc, Mindray Medical International Ltd., Philips Healthcare, ResMed, Smiths Group Plc, Vyaire Medical Inc. 등이 있습니다.
  • 지리적 동향 : 북미는 첨단 의료 인프라와 개인의 의료비 증가로 인해 기계식 인공호흡기 시장 예측의 중요한 촉진요인이 되고 있습니다. 이 외에도 유럽에서는 헬스케어 질과 환자의 안전성에 대한 관심이 높아지고 시장을 더욱 활성화시키고 있습니다. 또한 아시아태평양에서는 노인 인구 증가가 시장 성장에 긍정적인 영향을 미칩니다. 또한 라틴아메리카와 중동 및 아프리카에서는 개인의 의료비 지출이 증가하고 있으며 호흡기 질환에 대한 의식이 높아지고 있는 것도 시장 확대에 기여하고 있습니다.
  • 과제 및 기회 : 기계식 인공호흡기 시장 동향의 주요 과제 중 하나는 필수 의료기기의 부족 및 비용과 시간이 많이 걸리는 장비의 정기적인 유지보수 및 관리입니다. 그러나 인공지능 및 원격 모니터링과 같은 기술의 지속적인 발전과 재택 헬스케어의 새로운 추세는 시장에 큰 성장 기회를 제공합니다.

세계의 기계식 인공호흡기 시장 동향 :

만성 호흡기 질환 증가

천식, 급성 폐색성 폐 질환, 폐렴과 같은 만성 호흡기 질환의 증례 증가는 주로 기계식 인공호흡기 시장 통계를 견인하고 있습니다. 게다가 세계 COVID-19 팬데믹이 발생함에 따라 사망률, 이환율, 헬스케어 비용이 증가하여 시장 성장을 가속하고 있습니다. 따라서 다양한 의료기관들이 호흡기 질환의 발생을 최소화하기 위한 대책과 감염 예방에 주력하고 있습니다. 예를 들어, National Council on Aging의 데이터에 따르면 불규칙한 호흡과 뇌로의 산소 공급 감소를 특징으로 하는 폐색성 수면 무호흡 증후군(OSA)은 미국에서는 약 3,900만 명의 성인이 앓고 있으며, 전 세계적으로 9억 3,600만 명이 앓고 있는 것으로 추정되고 있습니다. 또한 미국 폐협회에 따르면 만성폐쇄성 폐질환(COPD)은 미국에서 질병별 사인의 3위로 1,640만 명 이상이 만성폐쇄성 폐질환으로 진단되고 있습니다.

기술 진보

인공호흡기의 휴대성, 모드, 사용자 인터페이스 개선 등 지속적인 기술 발전이 기계식 인공호흡기 시장을 확대하고 있습니다. 게다가, 재택 치료라는 새로운 동향에 의해 가정 환경에서 휴대용으로 사용자 친화적인 기기의 인기가 높아지고 있는 것도, 세계 시장을 활성화하고 있습니다. 이 외에도 자동화 기능과 고급 모니터링 기능을 갖춘 스마트 기계식 인공호흡기의 도입도 시장 성장에 긍정적인 영향을 미치고 있습니다. 예를 들어 Max Ventilator는 가습기와 산소 요법 기능을 갖춘 비침습성 인공호흡기를 발표하여 성인 및 신생아 의료에 대한 용도의 다양성을 보여주었습니다. 또한 Nihon Kohden OrangeMed, Inc. NKV-330 인공 호흡기 시스템의 미국 FDA 허가를 받았습니다.

정부 이니셔티브

호흡기 질환과 조기발견 및 치료의 중요성에 대한 인식을 높이기 위한 공중위생 캠페인 등 각국의 정부기관에 의한 여러 정책과 이니셔티브의 개시는 기계식 인공호흡기 시장 전망에 긍정적인 영향을 미치고 있습니다. 이와 더불어, 최신의 개선된 기계식 인공호흡기 도입을 위한 연구개발에 대한 규제당국에 의한 투자 증가도 시장 확대를 뒷받침하고 있습니다. 또한, 의료 인프라의 진보, 의료 종사자를 위한 교육 프로그램 및 세미나 증가가 기계식 인공 호흡기 시장의 수익을 더욱 밀어 올리고 있습니다. 예를 들어, CAIRE Inc.의 휴대용 산소 농축기 FreeStyle Comfort는 프랑스와 독일에서 보험 상환이 허가되어 환자의 접근성이 향상되었습니다. 이 회사는 이번 출시로 산소 요법 양식의 제품 포트폴리오를 확대했습니다. 또한 CorVent Medical은 CE 마크의 승인을 받아 유럽에서 RESPOND-19 인공 호흡기의 상업적 사용을 시작했습니다. 이 새로운 시스템은 사용하기 쉽고 중증 환자의 환기 능력을 유연하게 확장할 수 있도록 설계되었으며, 병원은 급성 호흡 곤란 증후군(ARDS)으로 고통받는 중증 환자의 치료를 개선할 수 있습니다.

목차

제1장 서문

제2장 조사 범위 및 조사 방법

  • 조사의 목적
  • 이해관계자
  • 데이터 소스
    • 1차 정보
    • 2차 정보
  • 시장 추정
    • 상향식 접근
    • 하향식 접근
  • 조사 방법

제3장 주요 요약

제4장 서문

  • 개요
  • 주요 업계 동향

제5장 COVID-19의 업계에 미치는 영향

제6장 세계의 기계식 인공호흡기 시장

  • 시장 개요
  • 시장 실적
  • 시장 예측

제7장 시장 내역 : 제품 유형별

  • 집중치료용 인공호흡기
  • 휴대용 및 보행용 인공호흡기
  • 기타

제8장 시장 내역 : 인터페이스별

  • 침습적
  • 비침습적

제9장 시장 내역 : 연령층별

  • 소아
  • 성인
  • 고령자

제10장 시장 내역 : 환기 모드별

  • 복합 환기 모드
  • 용량 제어 환기 모드
  • 압력 제어 환기 모드
  • 기타

제11장 시장 내역 : 최종 용도별

  • 병원 및 진료소
  • 홈케어
  • 외래 진료 센터
  • 기타

제12장 시장 내역 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동 및 아프리카
    • 시장 내역 : 국가별

제13장 SWOT 분석

  • 개요
  • 강점
  • 약점
  • 기회
  • 위협

제14장 밸류체인 분석

제15장 Porter's Five Forces 분석

  • 개요
  • 구매자의 협상력
  • 공급기업의 협상력
  • 경쟁도
  • 신규 참가업체의 위협
  • 대체품의 위협

제16장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업 프로파일
    • Allied Healthcare Products
    • Air Liquide
    • Asahi Kasei
    • GE Healthcare Company
    • Hamilton Medical AG
    • Maquet GmbH & Co. KG(Gatenge)
    • Medtronic Plc
    • Mindray Medical International Ltd.
    • Philips Healthcare
    • ResMed
    • Smiths Group Plc
    • Vyaire Medical Inc.
AJY 25.08.27

The global mechanical ventilators market size reached USD 5.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033. The market is primarily driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and respiratory disorders, the elevating number of individuals suffering from hypertension, diabetes, and cardiovascular diseases, and the continuous technological advancements, such as the development of non-invasive and portable mechanical ventilators.

Global Mechanical Ventilators Market Analysis:

  • Major Market Drivers: The growing prevalence of several respiratory disorders, including COPD, asthma, and pneumonia and the rising geriatric population are catalyzing the mechanical ventilators market growth. Besides this, the ongoing innovations, such as the development of improved ventilator portability, modes, and user interfaces are further stimulating the market expansion.
  • Key Market Trends: The inflating healthcare expenditure, mainly in developing economies, and the escalating demand for user-friendly and portable devices in homecare settings, on account of the emerging trend of home-based medical care, are propelling the medical ventilators market demand. Moreover, the market is continuing to grow as a result of the widespread use of intelligent variations with automated functions and cutting-edge monitoring capabilities.
  • Competitive Landscape: Some of the major market players in the mechanical ventilators market share include Allied Healthcare Products, Air Liquide, Asahi Kasei, GE Healthcare Company, Hamilton Medical AG, Maquet GmbH & Co. KG (Gatenge), Medtronic Plc, Mindray Medical International Ltd., Philips Healthcare, ResMed, Smiths Group Plc, and Vyaire Medical Inc., among others.
  • Geographical Trends: North America represents a significant driver of the mechanical ventilators market forecast, owing to its advanced healthcare infrastructure and the inflating medical expenditures of individuals. Besides this, the increasing focus of Europe on healthcare quality and patient safety is further catalyzing the market forward. Moreover, in the Asia Pacific region, the rising aging population is positively influencing the market growth. Moreover, the inflating medical care spending by individuals in Latin America and Middle East and Africa and the increasing awareness towards respiratory diseases are augmenting the market expansion.
  • Challenges and Opportunities: One of the major challenges of the mechanical ventilators market trends include the shortage of essential medical equipment and regular maintenance and servicing of devices, which is costly and time-consuming. However, the continuous advances in technology, including AI and remote monitoring, and the emerging trend of home-healthcare are presenting significant growth opportunities for the market.

Global Mechanical Ventilators Market Trends:

Increasing Cases of Chronic Respiratory Conditions

The rising cases of chronic respiratory conditions, including asthma, acute obstructive pulmonary disease, and pneumonia are primarily driving the mechanical ventilators market statistics. Moreover, the outbreak of the COVID-19 pandemic across the globe had increased mortality, morbidity, and healthcare costs, which is propelling the market growth forward. Therefore, various medical facilities are focusing highly on control measures and infection prevention to minimize the cases of such respiratory diseases. For instance, the National Council on Aging data indicated that Obstructive Sleep Apnea (OSA), characterized by irregular breathing and reduced oxygen supply to the brain, affected about 39 million adults in the U.S. and an estimated 936 million globally. Additionally, as per the American Lung Association, chronic obstructive pulmonary disease (COPD) is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with chronic obstructive pulmonary disease.

Technological Advancements

The ongoing technological advances, such as improved ventilator portability, modes, and user interfaces, are augmenting the mechanical ventilators market. Moreover, the growing popularity of portable and user-friendly devices in home settings, on account of the emerging trend of home-based medical care, is catalyzing the global market. Besides this, the introduction of smart mechanical ventilator variants with automated features and advanced monitoring capabilities is also positively influencing the market growth. For example, Max Ventilator introduced non-invasive ventilators featuring humidifiers and oxygen therapy capabilities, demonstrating versatility in applications for adult and neonatal care. Additionally, Nihon Kohden OrangeMed, Inc. received U.S. FDA clearance for the NKV-330 Ventilator System, which is non-invasive and provides respiratory support in emergencies.

Launch of Government Initiatives

The launch of several policies and initiatives by government bodies across countries, including public health campaigns to raise awareness about respiratory illnesses and the importance of early detection and treatment is positively influencing the mechanical ventilators market outlook. In addition to this, the inflating investments by regulatory authorities in research and development efforts for the introduction of the latest and improved mechanical ventilators are also propelling the market expansion. Moreover, the advancing healthcare infrastructures, along with the increasing number of training programs and seminars for medical professionals are further catalyzing the mechanical ventilators market revenue. For instance, CAIRE Inc.'s FreeStyle Comfort portable oxygen concentrator was authorized for reimbursement in France and Germany, enhancing patient access. The company extended its oxygen therapy modalities product portfolio through this launch. Furthermore, CorVent Medical received CE Mark approval and launched commercial use of its RESPOND-19 Ventilator in Europe. The novel system is designed for easy-to-use, flexible expansion of critical care ventilation capacity to allow hospitals to improve the treatment of critically ill patients suffering from acute respiratory distress syndrome (ARDS).

Global Mechanical Ventilators Market Segmentation:

Breakup by Product Type:

  • Intensive Care Ventilators
  • Portable/Ambulatory Ventilators
  • Others

Intensive care ventilators are developed for usage in critical care settings, such as intensive care units (ICUs) and emergency departments. They are capable of offering an advanced respiratory support to patients with severe respiratory failure or other critical conditions. On the other hand, portable/ambulatory ventilators are designed for use outside of traditional hospital settings, including in-home care, ambulances, or other transport settings. They are smaller, lighter, and more portable than intensive care variants, making them suitable for use in various places.

Breakup by Interface:

  • Invasive Ventilation
  • Non-Invasive Ventilation

Invasive ventilation typically comprises the insertion of a tube into the patient's airway, usually through the mouth or nose (endotracheal tube) or via a surgical opening in the neck (tracheostomy tube). This allows the ventilator to deliver air or oxygen directly into the lungs. Invasive ventilation is generally utilized for patients with severe respiratory failure or who are unable to breathe on their own. Moreover, non-invasive ventilation does not need the insertion of a tube into the airway of the individual. Instead, it uses a mask or similar device to deliver air or oxygen to the patient's lungs. Non-invasive ventilation is often used for patients with less severe respiratory failure or for patients who are able to breathe on their own but require the additional support.

Breakup by Age Group:

  • Pediatric
  • Adult
  • Geriatric

Pediatric ventilators are specifically created for infants and children. They are smaller in size and have features that cater to the unique respiratory needs of pediatric patients. These devices often include specialized modes and settings to deliver the appropriate level of support for smaller lungs and airways. Besides this, adult ventilators are designed for use in adult patients. They are larger and more robust than pediatric derivatives and are capable of providing the higher tidal volumes and pressures demanded for adult respiratory support. On the other hand, geriatric patients, who are typically older adults, may require ventilator support, owing to age-related respiratory conditions or complications.

Breakup by Mode of Ventilation:

  • Combined Mode of Ventilation
  • Volume Mode of Ventilation
  • Pressure Mode of Ventilation
  • Other Mode of Ventilation

Combined mode of ventilation, also referred to as dual or hybrid mode, combines the aspects of volume and pressure ventilation. It allows the ventilator to adjust the inspiratory pressure to maintain a set tidal volume, providing a more flexible and adaptable ventilation. Moreover, in volume mode of ventilation, the ventilator supplies a set tidal volume to the patient with each breath. This mode is commonly used in patients with normal lung compliance or when precise control over tidal volume is required, such as in acute respiratory distress syndrome (ARDS). Besides this, in pressure mode of ventilation, the ventilator delivers a set inspiratory pressure to the individual, allowing for a more variable tidal volume based on the lung compliance and resistance of the patient.

Breakup by End-Use:

  • Hospitals and Clinics
  • Home Care
  • Ambulatory Care Centers
  • Others

In hospitals and clinics, mechanical ventilators are utilized in intensive care units (ICUs), emergency departments, operating rooms, and general wards to support patients with acute respiratory failure, respiratory distress, or other conditions that require assisted ventilation. Additionally, these devices are increasingly being used in homecare settings to provide long-term respiratory support to patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or spinal cord injuries. Furthermore, ambulatory care centers, also known as outpatient clinics or day surgery centers, may utilize mechanical ventilators for patients undergoing procedures that require sedation or anesthesia, including endoscopic procedures or minor surgeries.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America represents a significant region of the mechanical ventilators market overview, owing to its advanced healthcare infrastructure and the inflating medical expenditures of individuals. Besides this, the increasing focus of Europe on healthcare quality and patient safety is further catalyzing the market forward. Moreover, in the Asia Pacific region, the rising aging population is positively influencing the market growth. Besides this, the inflating medical care spending by individuals in Latin America and Middle East and Africa and the increasing awareness towards respiratory diseases are augmenting the market expansion. For instance, according to a report published by the Centers for Disease Control and Prevention (CDC), out of all the hospitalizations caused by COVID-19, over 53% of patients were admitted to the intensive care unit. Additionally, based on a research study by Silvio A. Namendys-Silva et al., published in Critical Care, in Mexico, about 15.3% of hospitalized patients require invasive mechanical ventilation (IMV), and 70.8% of patients receive invasive mechanical ventilation (IMV) outside the ICU.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Mechanical Ventilators industry include:

  • Allied Healthcare Products
  • Air Liquide
  • Asahi Kasei
  • GE Healthcare Company
  • Hamilton Medical AG
  • Maquet GmbH & Co. KG (Gatenge)
  • Medtronic Plc
  • Mindray Medical International Ltd.
  • Philips Healthcare
  • ResMed
  • Smiths Group Plc
  • Vyaire Medical Inc.

Key Questions Answered in This Report

  • 1.How big is the mechanical ventilators market?
  • 2.What is the future outlook of mechanical ventilators market?
  • 3.What are the key factors driving the mechanical ventilators market?
  • 4.Which region accounts for the largest mechanical ventilators market share?
  • 5.Which are the leading companies in the global mechanical ventilators market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 COVID-19 Impact on the Industry

6 Global Mechanical Ventilators Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Intensive Care Ventilators
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Portable/Ambulatory Ventilators
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Interface

  • 8.1 Invasive Ventilation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-Invasive Ventilation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Age Group

  • 9.1 Pediatric
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Adult
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Geriatric
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Mode of Ventilation

  • 10.1 Combined Mode of Ventilation
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Volume Mode of Ventilation
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pressure Mode of Ventilation
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Other Mode of Ventilation
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by End-Use

  • 11.1 Hospitals and Clinics
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Home Care
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Ambulatory Care Centers
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Others
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Allied Healthcare Products
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Air Liquide
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Asahi Kasei
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 GE Healthcare Company
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Hamilton Medical AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Maquet GmbH & Co. KG (Gatenge)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Medtronic Plc
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Mindray Medical International Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Philips Healthcare
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 ResMed
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Smiths Group Plc
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Vyaire Medical Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제